Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
Eur J Epidemiol
    June 2022
  1. NARRES M, Claessen H, Kvitkina T, Rosenbauer J, et al
    Hospitalisation rate and mortality among people with and without diabetes during the COVID-19 pandemic year 2020.
    Eur J Epidemiol. 2022;37:587-590.
    >> Share

    May 2022
  2. VERBERK JDM, de Hoog MLA, Westerhof I, van Goethem S, et al
    Transmission of SARS-CoV-2 within households: a remote prospective cohort study in European countries.
    Eur J Epidemiol. 2022;37:549-561.
    >> Share

  3. CASPERSEN IH, Magnus P, Trogstad L
    Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort.
    Eur J Epidemiol. 2022;37:539-548.
    >> Share

    March 2022
  4. LEVIN AT, Jylhava J, Religa D, Shallcross L, et al
    COVID-19 prevalence and mortality in longer-term care facilities.
    Eur J Epidemiol. 2022;37:227-234.
    >> Share

  5. AXFORS C, Ioannidis JPA
    Infection fatality rate of COVID-19 in community-dwelling elderly populations.
    Eur J Epidemiol. 2022;37:235-249.
    >> Share

    February 2022
  6. HERGENS MP, Bell M, Haglund P, Sundstrom J, et al
    Risk factors for COVID-19-related death, hospitalization and intensive care: a population-wide study of all inhabitants in Stockholm.
    Eur J Epidemiol. 2022;37:157-165.
    >> Share

  7. HVIDE HK, Johnsen J
    COVID-19 and mental health: a longitudinal population study from Norway.
    Eur J Epidemiol. 2022;37:167-172.
    >> Share

    December 2021
  8. COLEMAN T, Sarian A, Grad S
    Re: Subramanian and Kumar. Vaccination rates and COVID-19 cases.
    Eur J Epidemiol. 2021;36:1245-1246.
    >> Share

  9. MULOT M, Segalas C, Leyrat C, Besancon L, et al
    Re: Subramanian and Kumar. Vaccination rates and COVID-19 cases.
    Eur J Epidemiol. 2021;36:1243-1244.
    >> Share

    The Authors' Reply: Need for a multi-pronged population-level strategy to manage SARS-CoV-2 infection.
    Eur J Epidemiol. 2021;36:1247-1251.
    >> Share

  11. GIANICOLO E, Wollschlager D, Blettner M
    Re: Subramanian and Kumar. Vaccination rates and COVID-19 cases.
    Eur J Epidemiol. 2021;36:1241-1242.
    >> Share

  12. BJORK J, Modig K, Kahn F, Ahlbom A, et al
    Revival of ecological studies during the COVID-19 pandemic.
    Eur J Epidemiol. 2021;36:1225-1229.
    >> Share

  13. WOLLSCHLAGER D, Gianicolo E, Blettner M, Hamann R, et al
    Association of COVID-19 mortality with COVID-19 vaccination rates in Rhineland-Palatinate (Germany) from calendar week 1 to 20 in the year 2021: a registry-based analysis.
    Eur J Epidemiol. 2021;36:1231-1236.
    >> Share

    Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States.
    Eur J Epidemiol. 2021;36:1237-1240.
    >> Share

    July 2021
  15. ESPENHAIN L, Tribler S, Svaerke Jorgensen C, Holm Hansen C, et al
    Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study.
    Eur J Epidemiol. 2021;36:715-725.
    >> Share

  16. BELLUCO S, Mancin M, Marzoli F, Bortolami A, et al
    Prevalence of SARS-CoV-2 RNA on inanimate surfaces: a systematic review and meta-analysis.
    Eur J Epidemiol. 2021;36:685-707.
    >> Share

  17. GOUDSMIT J, van den Biggelaar AHJ, Koudstaal W, Hofman A, et al
    Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program.
    Eur J Epidemiol. 2021;36:753-762.
    >> Share

  18. MCDONALD SA, Miura F, Vos ERA, van Boven M, et al
    Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands.
    Eur J Epidemiol. 2021;36:735-739.
    >> Share

  19. TELLE K, Jorgensen SB, Hart R, Greve-Isdahl M, et al
    Secondary attack rates of COVID-19 in Norwegian families: a nation-wide register-based study.
    Eur J Epidemiol. 2021;36:741-748.
    >> Share

  20. REICHER S, Ratzon R, Ben-Sahar S, Hermoni-Alon S, et al
    Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel.
    Eur J Epidemiol. 2021;36:727-734.
    >> Share

    June 2021
    Over- and under-estimation of COVID-19 deaths.
    Eur J Epidemiol. 2021;36:581-588.
    >> Share

  22. LICHER S, Terzikhan N, Splinter MJ, Velek P, et al
    Design, implementation and initial findings of COVID-19 research in the Rotterdam Study: leveraging existing infrastructure for population-based investigations on an emerging disease.
    Eur J Epidemiol. 2021;36:649-654.
    >> Share

  23. LUNDBERG JO, Zeberg H
    Longitudinal variability in mortality predicts COVID-19 deaths.
    Eur J Epidemiol. 2021;36:599-603.
    >> Share

  24. NAFILYAN V, Islam N, Mathur R, Ayoubkhani D, et al
    Ethnic differences in COVID-19 mortality during the first two waves of the Coronavirus Pandemic: a nationwide cohort study of 29 million adults in England.
    Eur J Epidemiol. 2021;36:605-617.
    >> Share

  25. POZO-MARTIN F, Weishaar H, Cristea F, Hanefeld J, et al
    The impact of non-pharmaceutical interventions on COVID-19 epidemic growth in the 37 OECD member states.
    Eur J Epidemiol. 2021;36:629-640.
    >> Share

    Different approaches to quantify years of life lost from COVID-19.
    Eur J Epidemiol. 2021;36:589-597.
    >> Share

  27. SCHMITZ T, Meisinger C, Kirchberger I, Thilo C, et al
    Impact of COVID-19 pandemic lockdown on myocardial infarction care.
    Eur J Epidemiol. 2021;36:619-627.
    >> Share

    May 2021
  28. BOTTCHER L, D'Orsogna MR, Chou T
    Using excess deaths and testing statistics to determine COVID-19 mortalities.
    Eur J Epidemiol. 2021;36:545-558.
    >> Share

  29. BATTY GD, Deary IJ, Gale CR
    Pre-pandemic cognitive function and COVID-19 mortality: prospective cohort study.
    Eur J Epidemiol. 2021;36:559-564.
    >> Share

    April 2021
  30. BUSHMAN M, Worby C, Chang HH, Kraemer MUG, et al
    Transmission of SARS-CoV-2 before and after symptom onset: impact of nonpharmaceutical interventions in China.
    Eur J Epidemiol. 2021;36:429-439.
    >> Share

  31. DE SOUZA FSH, Hojo-Souza NS, da Silva CM, Guidoni DL, et al
    Second wave of COVID-19 in Brazil: younger at higher risk.
    Eur J Epidemiol. 2021;36:441-443.
    >> Share

    March 2021
  32. BERGMAN J, Ballin M, Nordstrom A, Nordstrom P, et al
    Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study.
    Eur J Epidemiol. 2021;36:287-298.
    >> Share

  33. TERZIKHAN N, Hofman A, Goudsmit J, Ikram MA, et al
    External validity of phase III trials on vaccines against SARS-CoV-2 to a middle-aged and elderly Western European population.
    Eur J Epidemiol. 2021;36:319-324.
    >> Share

  34. ELLIOTT J, Bodinier B, Whitaker M, Delpierre C, et al
    COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors.
    Eur J Epidemiol. 2021;36:299-309.
    >> Share

  35. FAN X, Yin C, Wang J, Yang M, et al
    Pre-diagnostic circulating concentrations of insulin-like growth factor-1 and risk of COVID-19 mortality: results from UK Biobank.
    Eur J Epidemiol. 2021;36:311-318.
    >> Share

    February 2021
  36. PEARCE N, Vandenbroucke JP
    Arguments about face masks and Covid-19 reflect broader methodologic debates within medical science.
    Eur J Epidemiol. 2021;36:143-147.
    >> Share

  37. SKJEFTE M, Ngirbabul M, Akeju O, Escudero D, et al
    COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries.
    Eur J Epidemiol. 2021;36:197-211.
    >> Share

  38. ACCORSI EK, Qiu X, Rumpler E, Kennedy-Shaffer L, et al
    How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19.
    Eur J Epidemiol. 2021;36:179-196.
    >> Share

  39. CARRAT F, Figoni J, Henny J, Desenclos JC, et al
    Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort.
    Eur J Epidemiol. 2021;36:219-222.
    >> Share

  40. GIANICOLO EAL, Russo A, Buchler B, Taylor K, et al
    Gender specific excess mortality in Italy during the COVID-19 pandemic accounting for age.
    Eur J Epidemiol. 2021;36:213-218.
    >> Share

    January 2021
  41. PEARCE N, Moirano G, Maule M, Kogevinas M, et al
    Does death from Covid-19 arise from a multi-step process?
    Eur J Epidemiol. 2021;36:1-9.
    >> Share

    December 2020
  42. LEVIN AT, Hanage WP, Owusu-Boaitey N, Cochran KB, et al
    Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.
    Eur J Epidemiol. 2020;35:1123-1138.
    >> Share

    November 2020
  43. GOMEZ-OCHOA SA, Franco OH
    COVID-19: facts and failures, a tale of two worlds.
    Eur J Epidemiol. 2020;35:991-994.
    >> Share

  44. CATALANO R, Casey JA, Bruckner TA, Gemmill A, et al
    Non-COVID-19 deaths after social distancing in Norway.
    Eur J Epidemiol. 2020;35:1021-1024.
    >> Share

  45. HANAGE WP, Testa C, Chen JT, Davis L, et al
    COVID-19: US federal accountability for entry, spread, and inequities-lessons for the future.
    Eur J Epidemiol. 2020;35:995-1006.
    >> Share

  46. MILLS EHA, Moller AL, Gnesin F, Zylyftari N, et al
    National all-cause mortality during the COVID-19 pandemic: a Danish registry-based study.
    Eur J Epidemiol. 2020;35:1007-1019.
    >> Share

  47. HUANG J, Teoh JY, Wong SH, Wong MCS, et al
    The potential impact of previous exposure to SARS or MERS on control of the COVID-19 pandemic.
    Eur J Epidemiol. 2020;35:1099-1103.
    >> Share

    August 2020
  48. NADLER P, Wang S, Arcucci R, Yang X, et al
    An epidemiological modelling approach for COVID-19 via data assimilation.
    Eur J Epidemiol. 2020;35:749-761.
    >> Share

  49. TANERI PE, Gomez-Ochoa SA, Llanaj E, Raguindin PF, et al
    Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis.
    Eur J Epidemiol. 2020;35:763-773.
    >> Share

  50. PALAMENGHI L, Barello S, Boccia S, Graffigna G, et al
    Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy.
    Eur J Epidemiol. 2020;35:785-788.
    >> Share

  51. DROR AA, Eisenbach N, Taiber S, Morozov NG, et al
    Vaccine hesitancy: the next challenge in the fight against COVID-19.
    Eur J Epidemiol. 2020;35:775-779.
    >> Share

  52. CHIN V, Samia NI, Marchant R, Rosen O, et al
    A case study in model failure? COVID-19 daily deaths and ICU bed utilisation predictions in New York state.
    Eur J Epidemiol. 2020;35:733-742.
    >> Share

  53. BUCKEE CO, Johansson MA
    Individual model forecasts can be misleading, but together they are useful.
    Eur J Epidemiol. 2020;35:731-732.
    >> Share

  54. BARELLO S, Nania T, Dellafiore F, Graffigna G, et al
    'Vaccine hesitancy' among university students in Italy during the COVID-19 pandemic.
    Eur J Epidemiol. 2020;35:781-783.
    >> Share

  55. NADELLA P, Swaminathan A, Subramanian SV
    Forecasting efforts from prior epidemics and COVID-19 predictions.
    Eur J Epidemiol. 2020;35:727-729.
    >> Share

  56. CHOWDHURY R, Luhar S, Khan N, Choudhury SR, et al
    Long-term strategies to control COVID-19 in low and middle-income countries: an options overview of community-based, non-pharmacological interventions.
    Eur J Epidemiol. 2020;35:743-748.
    >> Share

    Containment strategies for the 2019 Novel Coronavirus: flatten the curve or crush it?
    Eur J Epidemiol. 2020;35:789-790.
    >> Share

    June 2020
  58. ORIVE G, Lertxundi U, Barcelo D
    Do we really need to invoke heroic measures for early SARS-CoV-2 outbreak detection?
    Eur J Epidemiol. 2020;35:613-614.
    >> Share

    Good science is good science: we need specialists, not sects.
    Eur J Epidemiol. 2020;35:519-522.
    >> Share

    May 2020
  60. CHOWDHURY R, Heng K, Shawon MSR, Goh G, et al
    Dynamic interventions to control COVID-19 pandemic: a multivariate prediction modelling study comparing 16 worldwide countries.
    Eur J Epidemiol. 2020;35:389-399.
    >> Share

  61. GEMES K, Talback M, Modig K, Ahlbom A, et al
    Burden and prevalence of prognostic factors for severe COVID-19 in Sweden.
    Eur J Epidemiol. 2020;35:401-409.
    >> Share

    April 2020
    Humanistic Epidemiology: Love in the time of cholera, COVID-19 and other outbreaks.
    Eur J Epidemiol. 2020;35:321-324.
    >> Share

  63. STANDL F, Jockel KH, Stang A
    COVID-19 and the need of targeted inverse quarantine.
    Eur J Epidemiol. 2020;35:339-340.
    >> Share

    Vaccine confidence in the time of COVID-19.
    Eur J Epidemiol. 2020;35:325-330.
    >> Share

    The paramount importance of serological surveys of SARS-CoV-2 infection and immunity.
    Eur J Epidemiol. 2020;35:331-333.
    >> Share

  66. SEBASTIANI G, Massa M, Riboli E
    Covid-19 epidemic in Italy: evolution, projections and impact of government measures.
    Eur J Epidemiol. 2020;35:341-345.
    >> Share

    The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments.
    Eur J Epidemiol. 2020;35:335-337.
    >> Share

  68. CHEN Y, Zhang J, Chu X, Xu Y, et al
    Vaccines and the risk of Guillain-Barre syndrome.
    Eur J Epidemiol. 2020;35:363-370.
    >> Share

    January 2020
  69. GUNNES N, Gjessing HK, Bakken IJ, Ghaderi S, et al
    Seasonal and pandemic influenza during pregnancy and risk of fetal death: A Norwegian registry-based cohort study.
    Eur J Epidemiol. 2020 Jan 16. pii: 10.1007/s10654-020-00600.
    >> Share

    December 2019
  70. GHADERI S, Berg-Hansen P, Bakken IJ, Magnus P, et al
    Hospitalization following influenza infection and pandemic vaccination in multiple sclerosis patients: a nationwide population-based registry study from Norway.
    Eur J Epidemiol. 2019 Dec 23. pii: 10.1007/s10654-019-00595.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016